Assignee
SEINDA PHARMACEUTICAL GUANGZHOU CORP
CN·2 granted patents·4 pending applications·1 citations·filing 2018–2023
Top patents by PatentIndex Score
6 records- 0179US11285141B2Composition and methods for the treatment of myopiaSEINDA PHARMACEUTICAL GUANGZHOU CORP·Filed 2018·Granted Mar 29, 2022·1 cites·18 claims
- 0270US12102628B2Composition and methods for the treatment of myopiaSEINDA PHARMACEUTICAL GUANGZHOU CORP·Filed 2022·Granted Oct 1, 2024·0 cites·15 claims
- 0364US2024148818A1Ophthalmic pharmaceutical composition and its preparation methods and applicationsSEINDA PHARMACEUTICAL GUANGZHOU CORP·Filed 2023·Application pending·0 cites
- 0451US2021030833A1Ophthalmic pharmaceutical composition, preparation method therefor and application thereofSEINDA PHARMACEUTICAL GUANGZHOU CORP·Filed 2019·Application pending·0 cites
- 0549US2025057909A1Novel use of alanyl-glutamine and ophthalmic composition comprising alanyl-glutamineSEINDA PHARMACEUTICAL GUANGZHOU CORP·Filed 2022·Application pending·0 cites
- 0647US2021308102A1Compositions and methods for treatment of presbyopiaSEINDA PHARMACEUTICAL GUANGZHOU CORP·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SEINDA PHARMACEUTICAL GUANGZHOU CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →